warnings
Warnings For external use only
Xpect Extra Strength Itch Relief
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Xpect Extra Strength Itch Relief
- Generic name
- DIPHENHYDRAMINE HYDROCHLORIDE
- Manufacturer
- Cintas Corporation
- Product type
- HUMAN OTC DRUG
- SPL set ID
- a373b2c3-5c58-4b64-9358-bdf42dfce08c
- SPL ID
- 43b08582-e9bb-4ba4-a2ca-7eab3c9c16c6
- Version
- 4
- Effective date
- 2025-09-24
- Source export date
- 2026-09-28
- Source partition
- 13
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:37:47
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M017 | openfda.application_number | |
| brand name | Xpect Extra Strength Itch Relief | openfda.brand_name | |
| generic name | DIPHENHYDRAMINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | Cintas Corporation | openfda.manufacturer_name | |
| ndc | package | 42961-218-01 | openfda.package_ndc |
| ndc | product | 42961-218 | openfda.product_ndc |
| ndc11 | package | 42961021801 | derived:openfda.package_ndc |
| rxcui | 1050080 | openfda.rxcui | |
| spl id | 43b08582-e9bb-4ba4-a2ca-7eab3c9c16c6 | id | |
| spl set id | a373b2c3-5c58-4b64-9358-bdf42dfce08c | set_id | |
| unii | TC2D6JAD40 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.